ArticleChemistry & biodiversity2026
Anti-Inflammatory Potential of Key Phytochemicals From Humboldtia sanjappae: In Vivo Studies and Molecular Docking With MM-GBSA Analysis.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Humboldtia sanjappae, an endemic medicinal plant, was examined for its anti-inflammatory properties using both in vivo and in silico methodologies. The anti-inflammatory activity was assessed utilizing carrageenan-induced and formalin-induced paw oedema models in Swiss albino mice. The ethanolic extract of H. sanjappae demonstrated significant, dose-dependent inhibition of inflammation. Phytochemical analysis identified bioactive flavonoids, with neoeriocitrin demonstrating the highest binding affinity for TNF-α in molecular docking studies, indicating its significant role in inflammation modulation. Subsequent docking studies targeting COX-2, IL-6, and IL-1β revealed advantageous interactions, validated by MM-GBSA free energy analyses. Although COX-1, crucial for normal physiological function, was also inhibited, no adverse effects were noted, suggesting that the extract may function as a nonselective COX inhibitor similar to indomethacin. These findings highlight the therapeutic potential of H. sanjappae as a natural source of anti-inflammatory agents that target different pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.